{"log_id": 1269942872747533550, "direction": 0, "words_result_num": 23, "words_result": [{"probability": {"variance": 0.001188, "average": 0.985641, "min": 0.827956}, "location": {"width": 836, "top": 233, "height": 54, "left": 182}, "words": "( VEGFR-1、 VEGFR-2和 VEGFR-3)。这些受体与病理性血管生成、肿瘤生长和癌症"}, {"probability": {"variance": 0.004454, "average": 0.984603, "min": 0.59557}, "location": {"width": 847, "top": 290, "height": 52, "left": 174}, "words": "进展相关。体外试验与小鼠体内模型试验显示阿昔替尼可抑制VEGF介导的内皮细胞增"}, {"probability": {"variance": 0.007334, "average": 0.980817, "min": 0.49912}, "location": {"width": 780, "top": 346, "height": 52, "left": 175}, "words": "殖与存活;在荷瘤小鼠模型中,阿昔替尼可抑制肿瘤生长及 VEGFR-2的磷酸化"}, {"probability": {"variance": 5.7e-05, "average": 0.993917, "min": 0.980922}, "location": {"width": 90, "top": 421, "height": 27, "left": 177}, "words": "毒理研究"}, {"probability": {"variance": 2.3e-05, "average": 0.997278, "min": 0.979181}, "location": {"width": 804, "top": 452, "height": 53, "left": 220}, "words": "遗传毒性:阿昔替尼Ames试验和人淋巴细胞染色体畸变试验结果为阴性,小鼠骨"}, {"probability": {"variance": 2.1e-05, "average": 0.997581, "min": 0.984974}, "location": {"width": 208, "top": 525, "height": 36, "left": 177}, "words": "髓微核试验结果阳性"}, {"probability": {"variance": 2.1e-05, "average": 0.997211, "min": 0.983066}, "location": {"width": 800, "top": 561, "height": 54, "left": 225}, "words": "生殖毒性:阿昔替尼可能损害人的生殖功能和生育力。在重复给药毒性试验中,小"}, {"probability": {"variance": 0.002581, "average": 0.985295, "min": 0.693457}, "location": {"width": 831, "top": 616, "height": 54, "left": 178}, "words": "鼠经口给药2次/天,≥15mg/kg/剂量(约为人推荐起始剂量时系统暴露(AUC)的"}, {"probability": {"variance": 0.014614, "average": 0.946662, "min": 0.473749}, "location": {"width": 845, "top": 668, "height": 56, "left": 182}, "words": "倍),或犬经口给药2次/天,≥1,5mgkg/剂量(约为人推荐起始剂量时系统暴露的0.1"}, {"probability": {"variance": 0.00063, "average": 0.993043, "min": 0.851664}, "location": {"width": 845, "top": 724, "height": 53, "left": 182}, "words": "倍),可引起雄性动物睾丸/附睾重量降低、萎缩或退化、生发细胞数量减少、精子减少"}, {"probability": {"variance": 0.003931, "average": 0.987649, "min": 0.599524}, "location": {"width": 848, "top": 779, "height": 53, "left": 182}, "words": "或异常精子形成,精子密度或计数减少;在≥5mg/kg剂量(大鼠与犬分别是人推荐起"}, {"probability": {"variance": 0.000392, "average": 0.993899, "min": 0.897789}, "location": {"width": 846, "top": 835, "height": 51, "left": 184}, "words": "始剂量时系统暴露的1.5倍或0.3倍)下可见雌性小鼠和雌性犬生殖道异常,包括性成"}, {"probability": {"variance": 3e-06, "average": 0.998752, "min": 0.992018}, "location": {"width": 545, "top": 896, "height": 44, "left": 183}, "words": "熟延迟、黄体数减少或缺失、子宫重量降低和子宫萎缩"}, {"probability": {"variance": 0.001214, "average": 0.990871, "min": 0.784355}, "location": {"width": 800, "top": 946, "height": 47, "left": 230}, "words": "小鼠生育力试验中,雄性小鼠经口给药2次/天,至少70天,阿昔替尼50mg/kg"}, {"probability": {"variance": 0.00018, "average": 0.996249, "min": 0.917566}, "location": {"width": 825, "top": 998, "height": 51, "left": 185}, "words": "剂量(约为人推荐起始剂量时系统暴露的57倍)对雄性小鼠交配率与生育率未见影响"}, {"probability": {"variance": 0.002963, "average": 0.980921, "min": 0.747612}, "location": {"width": 848, "top": 1052, "height": 51, "left": 187}, "words": "雌性小鼠经口给药2次/天,至少15天,≥15mg/kg/剂量(约为人推荐起始剂量时系统"}, {"probability": {"variance": 9.4e-05, "average": 0.996953, "min": 0.950054}, "location": {"width": 555, "top": 1113, "height": 44, "left": 187}, "words": "暴露的10倍)可引起雌性小鼠生育力及胚胎存活率降低"}, {"probability": {"variance": 0.000602, "average": 0.991908, "min": 0.84998}, "location": {"width": 803, "top": 1159, "height": 53, "left": 233}, "words": "在胚胎胎仔毒性研究中,妊娠小鼠在脏器形成期间经口给予阿昔替尼,剂量为0.15"}, {"probability": {"variance": 0.006878, "average": 0.971292, "min": 0.489616}, "location": {"width": 852, "top": 1215, "height": 55, "left": 190}, "words": "05、1.5mg/kg,2次/天。1.5mg/kg剂量(约为人推荐起始剂量时系统暴露量的0.5倍)"}, {"probability": {"variance": 0.011626, "average": 0.967936, "min": 0.368057}, "location": {"width": 846, "top": 1271, "height": 52, "left": 191}, "words": "时可见胚胎-胎仔毒性,包括畸形(腭裂);在≥0.5mg/kg剂量(约为人体推荐起始剂"}, {"probability": {"variance": 0.000214, "average": 0.995692, "min": 0.928769}, "location": {"width": 462, "top": 1334, "height": 46, "left": 191}, "words": "的系统暴露量的0.15倍)时可见骨骼钙化异常"}, {"probability": {"variance": 4e-05, "average": 0.994093, "min": 0.979958}, "location": {"width": 140, "top": 1592, "height": 30, "left": 553}, "words": "第23页,共27页"}, {"probability": {"variance": 0.006913, "average": 0.959062, "min": 0.717475}, "location": {"width": 93, "top": 1628, "height": 22, "left": 257}, "words": "No:2015042"}], "language": 3}